Philip Morris International is executing a transformative shift toward smoke-free products, driving high single-digit organic growth and expanding margins. PM delivered $40.6B in 2025 revenue (+7.3% YoY), with smoke-free products now 41.5% of net revenues and ZYN dominating the U.S. nicotine pouch market. I am upgrading my rating to bullish, citing strong 2026 guidance, double-digit EPS growth, and an attractive 3.67% dividend yield.

Philip Morris International (NYSE:PM) reports Q1 2026 earnings on April 22, before the market opens.

Stratos Wealth Partners LTD. lessened its holdings in shares of Philip Morris International Inc. (NYSE: PM) by 17.0% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 36,479 shares of the company's stock after selling 7,447 shares during the period. Stratos Wealth Partners LTD.'s

Savvy Advisors Inc. increased its stake in Philip Morris International Inc. (NYSE: PM) by 49.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 26,512 shares of the company's stock after purchasing an additional 8,802 shares during the quarter. Savvy Advisors Inc.'s holdings

Aberdeen Group plc trimmed its position in shares of Philip Morris International Inc. (NYSE: PM) by 11.4% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 701,413 shares of the company's stock after selling 89,923 shares during the period. Aberdeen

Retail sales were strong in February, but likely got worse in March. Dollar General should be a beneficiary of consumers trading down.

Philip Morris has a strong position in the nicotine market, which should help its dividend grow. Investors are too pessimistic about Pfizer's future, even as it pays a huge dividend yield right now.

Analysts view a reported FDA delay as a negative for the tobacco giant.

Stocks are higher to start April amid rare geopolitical optimism, with the ADP jobs report also in focus

Philip Morris International shares are trading lower Wednesday morning after Reuters reported that the FDA's planned fast-track review for certain nicotine pouch applications has slowed.